학술논문
Efficacy and safety of glecaprevir/pibrentasvir in patients with chronic hepatitis C virus genotype 5 or 6 infection (ENDURANCE-5,6): an open-label, multicentre, phase 3b trial
Document Type
Article
Author
Source
In The Lancet Gastroenterology & Hepatology January 2019 4(1):45-51
Subject
Language
ISSN
2468-1253